Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 2
1962 3
1963 9
1964 4
1965 6
1966 3
1967 3
1968 2
1969 2
1970 3
1971 10
1972 9
1973 4
1974 2
1975 3
1976 7
1977 6
1978 4
1979 3
1980 12
1981 4
1982 9
1983 15
1984 8
1985 7
1986 3
1987 4
1988 7
1989 11
1990 1
1991 3
1992 9
1993 8
1994 10
1995 2
1996 5
1997 2
1998 3
1999 5
2000 4
2001 2
2002 4
2003 3
2004 3
2005 4
2006 6
2007 4
2008 3
2009 7
2010 5
2011 5
2012 4
2013 4
2014 4
2015 5
2016 4
2017 4
2018 1
2019 1
2020 3
2022 1
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.
Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saußele S, Schiffer C, Silver R, Simonsson B, Steegmann JL, Goldman JM, Hehlmann R. Baccarani M, et al. Among authors: simonsson b. Blood. 2013 Aug 8;122(6):872-84. doi: 10.1182/blood-2013-05-501569. Epub 2013 Jun 26. Blood. 2013. PMID: 23803709 Free PMC article. Review.
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ; IRIS Investigators. O'Brien SG, et al. Among authors: simonsson b. N Engl J Med. 2003 Mar 13;348(11):994-1004. doi: 10.1056/NEJMoa022457. N Engl J Med. 2003. PMID: 12637609 Free article. Clinical Trial.
Bronchoconstrictor drugs.
Simonsson BG, Svedmyr N. Simonsson BG, et al. Pharmacol Ther B. 1977;3(2):239-303. doi: 10.1016/0306-039x(77)90035-6. Pharmacol Ther B. 1977. PMID: 22879 Review. No abstract available.
Epidemiology of chronic myeloid leukaemia: an update.
Höglund M, Sandin F, Simonsson B. Höglund M, et al. Among authors: simonsson b. Ann Hematol. 2015 Apr;94 Suppl 2:S241-7. doi: 10.1007/s00277-015-2314-2. Epub 2015 Mar 27. Ann Hematol. 2015. PMID: 25814090 Review.
Exercise-induced airways constriction.
Simonsson BG, Skoogh BE, Ekström-Jodal B. Simonsson BG, et al. Thorax. 1972 Mar;27(2):169-80. doi: 10.1136/thx.27.2.169. Thorax. 1972. PMID: 4624586 Free PMC article.
Drugs in the treatment of asthma.
Svedmyr N, Simonsson BG. Svedmyr N, et al. Among authors: simonsson bg. Pharmacol Ther B. 1978;3(4):397-440. doi: 10.1016/s0306-039x(78)90005-3. Pharmacol Ther B. 1978. PMID: 32558 Review. No abstract available.
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.
Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R; European LeukemiaNet. Baccarani M, et al. Among authors: simonsson b. J Clin Oncol. 2009 Dec 10;27(35):6041-51. doi: 10.1200/JCO.2009.25.0779. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884523 Free PMC article. Review.
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders.
Bonifazi F, de Vivo A, Rosti G, Guilhot F, Guilhot J, Trabacchi E, Hehlmann R, Hochhaus A, Shepherd PC, Steegmann JL, Kluin-Nelemans HC, Thaler J, Simonsson B, Louwagie A, Reiffers J, Mahon FX, Montefusco E, Alimena G, Hasford J, Richards S, Saglio G, Testoni N, Martinelli G, Tura S, Baccarani M; Europena Study Group on Interferon in Chronic Myeloid Leukemia; Italian Cooperative Study Group on CML; France Intergroup of CML; German CML Study Group; UK Medical Research Council Working Party on CML; Spanish CML Study Group; Australian CML Study Group; Swedish CML Study Group. Bonifazi F, et al. Among authors: simonsson b. Blood. 2001 Nov 15;98(10):3074-81. doi: 10.1182/blood.v98.10.3074. Blood. 2001. PMID: 11698293 Free article. Review.
288 results